Companies & Industry »Company News
Aurobindo Pharma Ltd - Company News

BSE   18 Aug 17 | 12:00 AM

704.50 1 (0.14%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 524804
Face Value: 1

NSE   18 Aug 17 | 12:00 AM

704.75 1.25 (0.18%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: AUROPHARMA
Performance
1 Week : Rs 704.80 (-0.04%)
1 Month : Rs 766.65 (-8.11%)
1 Year : Rs 763.65 (-7.75%)
change companytradenow

  • 30 May 17
    11:29 AM
    Representative imageEven with muted outlook for the pharma sector, Aurobindo Pharma, today, rose as much as 10.6% in today’s trade after the company yesterday said  is confident about FY18 growth despite weak Q4 earnings.
  • 10 Jan 17
    05:52 AM
    Leveraging on a new acquisition and its existing product pipeline that includes potential launches of molecules going off-patent in the new year, Aurobvindo Pharma Limited is aiming to double its revenues in Europe to Euro 1 billion in the next 3-5 years.
  • 14 Nov 16
    10:14 PM
    Hyderabad-based Aurobindo Pharma Limited has reported a 33.5% jump in consolidated net profit at Rs 605.64 crore for the quarter ended September 2016 on the back of higher growth in formulations business in the US market.
  • 24 Aug 16
    10:04 AM
    Aurobindo Pharma has rallied 6% to Rs 778 on the BSE in early morning trade after the company reported 24% year on year  (YoY)jump in consolidated net profit at Rs 585 crore for the quarter ended June 30, 2016 (Q1FY17),  on the back of higher
  • 23 Aug 16
    09:05 PM
    Indian generics pharmaceutical company Aurobindo Pharma Limited has reported a 24% increase in consolidated net profit at Rs 584.6 crore for the quarter ended June, 2016 driven by double-digit sales growth across major markets led by the US formulations
  • 25 Jul 16
    12:39 AM
    Hyderabad-based Aurobindo Pharmaceuticals is planning to raise funds via a share sale to fund the acquisition of Israel-based Teva Pharmaceutical’s European assets, if its bid is accepted by this month.
  • 21 Jul 16
    07:21 AM
    In what could boost their fortunes significantly, three Indian companies — Sun Pharma, Aurobindo Pharma and Glenmark Pharma — have received approval from the United States Food and Drug Administration (USFDA) to manufacture and market generic
  • 20 Jul 16
    06:56 PM
    In what could boost their fortunes significantly, three Indian companies - Sun Pharma, Aurobindo Pharma and Glenmark Pharma - have received approval from United States Food & Drug Administration (USFDA) to manufacture and market generic versions of
    11:34 AM
    In a major development, Aurobindo Pharma announced on Wednesday that the company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market cholesterol lowering Rosuvastatin Calcium Tablets, 5 mg (base), 10 mg
    10:17 AM
    Aurobindo Pharma has moved higher by 4% to Rs 788 on the BSE after the company said that it has received nod from the US drug regulator to manufacture and market Rosuvastatin Calcium tablets.
  • 09 Jul 16
    10:44 PM
    Aurobindo Pharma is likely to be the second Hyderabad-based company actively looking at acquiring ‘overlapping products’ from Israeli generic drugs major Teva, this time in Europe.
  • 06 Jul 16
    01:04 PM
    Aurobindo Pharma Limited is likely to be the second Hyderabad-based company actively looking at acquiring the 'overlapping products' from Israeli generics drug major Teva, this time in Europe.
1|2|3|4|5|6|7|8|9|10|11|Next
Widgets Magazine

Sensex

Company Price Gain (%)
Hind. Unilever1,199.702.13
Power Grid Corpn222.851.55
TCS2,512.851.32
Bharti Airtel421.601.21
ITC281.800.84
Widgets Magazine

Messages

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine